Rosetta Omics
Personalized cancer treatment through proteomic profiling
- B2B
About Rosetta Omics
The company specializes in high resolution proteomic profiling to improve prediction of treatment response in cancer patients for precision medicine
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2022
- Revenue
- $4.1M – $32.2MTamtam estimate
- Website
- rosetta-omics.com
Rosetta Omics at a glance
Rosetta Omics is a B2B company in the Biotechnology Research industry, headquartered in Paris, Île-de-France, France.
Rosetta Omics was founded in 2022.
Rosetta Omics has 11–50 employees.
Rosetta Omics's revenue is $4.1M – $32.2M (Tamtam estimate).
Selling to companies like Rosetta Omics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies